Another great post @Mason14
I would also add that this is another piece of evidence of the importance of FTO as a target. The major risk we have right now with Bisantrene as a FTO targeted agent is knowing if FTO is going to be important in treating patients. Every new drug that comes along targeting FTO and killing cancer cells decreases this risk.
Pillar 1 - FTO (new thread), page-906
-
- There are more pages in this discussion • 2,086 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.165(11.5%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.61 | $1.46 | $245.3K | 161.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 229 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 1226 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |